Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Agnieszka Stelmaszyk"'
Autor:
Agnieszka Stelmaszyk, Anna Wesołowska, Karolina Pomieczyńska, Saule Iskakova, Magdalena Frydrychowicz, Grzegorz Dworacki, Marzena Dworacka
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 8, Pp 1192-1198 (2018)
Introduction: Cardiovascular risk in the course of diabetes depends greatly on glycemic variability which is even more significant than chronic hyperglycemia. Optimal management of diabetes involves a multidisciplinary approach focused in particular
Externí odkaz:
https://doaj.org/article/b3d6358f6a5f4d54b54598ed2b4581f2
Autor:
Marzena Dworacka, Saule Iskakova, Magdalena Frydrychowicz, Karolina Pomieczyńska, Anna Wesołowska, Agnieszka Stelmaszyk, Grzegorz Dworacki
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 8, Pp 1192-1198 (2018)
Introduction: Cardiovascular risk in the course of diabetes depends greatly on glycemic variability which is even more significant than chronic hyperglycemia. Optimal management of diabetes involves a multidisciplinary approach focused in particular
Autor:
Marzena Dworacka, Agnieszka Stelmaszyk
Publikováno v:
Clinical Diabetology. 7:164-170
The level of expression of certain genes modifying the phenotype may affect the progression of diabetes mellitus and its complications. Gene expression is controlled by epigenetic modifications, influenced by intracellular and environmental factors,
Publikováno v:
European Journal of Pharmacology. 907:174289
SIRT1 (sirtuin 1, a member of histone deacetylase III family) is responsible for deacetylation of lysine in histones and the conservation of DNA in the state of transcriptionally inactive heterochromatin. SIRT1 is also capable of deacetylation of tra
Autor:
Marzena Dworacka, Agnieszka Stelmaszyk
Publikováno v:
Clinical Diabetology. 6:142-146
The following paper is an attempt to revise current data and the results of clinical trials concerning the impact of dapagliflozin on long-term cardiovascular complications of type 2 diabetes mellitus. Short-term clinical trials, including relatively
Autor:
Gulmira Zharmakhanova, Anna Wesołowska, Bartosz Adam Frycz, Marzena Dworacka, Agnieszka Stelmaszyk, Grzegorz Dworacki, Saule Iskakova, Paweł P. Jagodziński
Publikováno v:
Diabetes research and clinical practice. 143
Aim Over the last few years, studies have indicated that fluctuant hyperglycemia is very likely to increase the risk of cardiovascular complications of diabetes. Statins are widely used in diabetes for the prevention of cardiovascular complications,
Autor:
Olzhas Urazayev, Marzena Dworacka, Anna Wesołowska, Hanna Winiarska, Saule Iskakova, Agnieszka Stelmaszyk, Gulmira Zharmankhanova
Publikováno v:
Pharmacological Reports. 67:43